Implementation strategies to guide providers on the management of QT-prolonging medications: a clinical quality improvement tool presented in an interprofessional education workshop
Journal of Pharmaceutical Health Services Research · 14.04.2026 · 17 (2)
DOI: 10.1093/jphsr/rmag012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Health Services Research, online erschienen am 18.05.2026. Verfasst von Naga Goli und 6 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Objectives
To evaluate the impact of a pharmacist-led clinical quality improvement tool and interprofessional education on the management of patients receiving QT-prolonging medications (QTPMs), and to implement a risk assessment and treatment algorithm incorporating alternative therapies to support best-practice prescribing decisions.
Methods
A pre- and post-intervention design was utilized to evaluate the impact of an interprofessional educational workshop and a clinical quality improvement tool on providers’ knowledge and clinical practice regarding QTPM management. A total of 26 providers attended and completed the pre- and post-surveys. The pre-intervention survey assessed provider knowledge and comfort in managing QTPMs. The post-intervention survey evaluated the effect of the tool on providers’ comfort and perception. A total of 148 patients under participant care were reviewed, with 115 patients aged ≥18 years and receiving QTPMs included in the analysis. Key findings A total of 26 providers attended. The percentage of providers who felt very comfortable managing patients receiving QTPMs increased (8% vs. 15%), and the percentage of providers who felt very uncomfortable reduced (8% vs. 0%). Most providers (78%) could identify lower-risk QTPMs using the intervention tool. The percentage change in the QT-prolongation mean risk score was statistically significant post-intervention (9.14% decrease; P = .0244). Furthermore, the proportion of electrocardiogram orders for patients receiving QTPMs decreased after the intervention (43% decrease; P = .003).
Conclusion
Implementing a pharmacist-led risk tool featuring alternative therapeutic recommendations may positively impact providers’ knowledge and clinical practice in managing QTPMs.
Zitieren
APA
Goli, N., Ballo, J., Gilbert, J., McGee, R., Shin, H., Collopy, E., & Batarseh, Y. S. (2026). Implementation strategies to guide providers on the management of QT-prolonging medications: a clinical quality improvement tool presented in an interprofessional education workshop. Journal of Pharmaceutical Health Services Research, 17(2). https://doi.org/10.1093/jphsr/rmag012
Vancouver
Goli N, Ballo J, Gilbert J, McGee R, Shin H, Collopy E, et al. Implementation strategies to guide providers on the management of QT-prolonging medications: a clinical quality improvement tool presented in an interprofessional education workshop. Journal of Pharmaceutical Health Services Research. 2026;17(2). doi:10.1093/jphsr/rmag012
BibTeX
@article{Goli2026,
author = {Goli, Naga and Ballo, Julie and Gilbert, Judson and McGee, Robert and Shin, Hyun and Collopy, Erin and Batarseh, Yazan S},
title = {Implementation strategies to guide providers on the management of QT-prolonging medications: a clinical quality improvement tool presented in an interprofessional education workshop},
journal = {Journal of Pharmaceutical Health Services Research},
year = {2026},
volume = {17},
number = {2},
doi = {10.1093/jphsr/rmag012}
}
EUVIMED